- Grants since 2016
- 586
- Awarded, last 5 years (where amounts are published)
- CAD 165.4M
- Funded works, last 5 years
- 578
- Funded works, all time
- 2 936
Grants
2017–2020 · research · Breast Cancer Research Grants Program
Pharmacogenomic discovery of predictive cardiotoxicity biomarkers in breast cancer patients receiving anthracycline chemotherapies
Colin Ross · University of British Columbia
2017–2019 · research · Knowledge to Action Grants
Implementing lung cancer screening for those living with low income
Aisha Lofters · St. Michael's Hospital
2017–2022 · research · Impact Grants
Targeting the Wnt pathway in cancer with therapeutic antibodies
Stephane Angers · University of Toronto
2017–2020 · research · Breast Cancer Research Grants Program
A functional approach to assessing variants of unknown significance in BRCA1 carriers
Scott Davey · Queens University
2017–2020 · research · Breast Cancer Research Grants Program
Rationalized depletion of mammary progenitors as a program for breast cancer prevention
Rama Khokha · University Health Network
2017–2020 · research · Breast Cancer Research Grants Program
Clinical utility of immune response biomarkers for aggressive breast cancers
Torsten Nielsen · Vancouver General Hospital
2017–2019 · research · Prevention Innovation Grants
Social deprivation and environment, and risk of prostate cancer
Marie-Elise Parent · Institut National de la Recherche Scientifique
2017–2020 · research · Breast Cancer Research Grants Program
Targeting p53-mutated triple-negative breast cancer: role of nuclear factor IB
Roseline Godbout · University of Alberta
2017–2020 · research · Breast Cancer Research Grants Program
Quantitative standardized estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) for prognostic and/or predictive index for response to adjuvant aromatase inhibitors exemestane or anastrozole
Lois Shepherd · Queens University
2017–2020 · research · Breast Cancer Research Grants Program
Targeting breast cancer via combined natural killer T cell immunotherapy and oncolytic virotherapy
Brent Johnston · Dalhousie University
2017–2020 · research · Breast Cancer Research Grants Program
Novel cell-free DNA assays to predict relapse and guide systemic therapy in early breast cancer
David Cescon · University Health Network
2017–2019 · research · Knowledge to Action Grants
Improving rectal cancer survivorship by reducing the incidence of parastomal hernias
Nancy Baxter · St. Michael's Hospital
2017–2020 · research · Breast Cancer Research Grants Program
Breast cancer treatment in women with PALB2 mutations
Kelly Metcalfe · University of Toronto
2017–2020 · research · Prevention Innovation Grants
Innovations for assessing occupational exposure to carcinogens in population based studies
Paul Demers · Cancer Care Ontario
2017–2019 · research · Knowledge to Action Grants
Realizing the benefits of a palliative approach for vulnerable and marginalized people living with cancer
Kelli Stajduhar · University of Victoria
2017–2020 · research · Breast Cancer Research Grants Program
Delineating a role of RANKL/OPG-signalling on breast cancer development
Joanne Kotsopoulos · Women's College Hospital
2017–2022 · research · PCC Targeted Radionuclide Therapy
National Program on Radioligand Therapy for Prostate Cancer
Francois Benard · Provincial Health Services Authority
2017–2022 · research · Impact Grants
A novel tyrosine kinase oncogenic signalling pathway with therapeutic potential in hepatocellular carcinoma
Sylvain Meloche · Université de Montréal
2017–2020 · research · Breast Cancer Research Grants Program
Small molecules targeting aberrant STAT3 activity in breast cancer: killing breast tumour cells and inducing anti-tumour immune response
Patrick Gunning · University of Toronto
2017–2018 · research · Knowledge to Action Grants
Evaluating the impact of cancer screening patient decision aids accessed through the McMaster Optimal Aging Portal
Maureen Dobbins · McMaster University
2017–2022 · research · Impact Grants (co-funded with Brain Canada with the financial support of Health Canada)
Advancing biology-based therapies for rhabdoid brain tumours
Annie Huang · Great Ormond Street Hospital
2017–2020 · research · Prevention Innovation Grants
Investigation of novel risk factors to understand the etiology of young- onset colorectal cancer and the alarming increasing incidence
Michelle Cotterchio · Cancer Care Ontario
2017–2020 · research · Breast Cancer Research Grants Program
LA LEAST. Luminal A, Limited Endocrine Adjuvant Systemic Therapy, a phase II trial of abbreviated hormone therapy for low risk hormone receptor positive, HER2 negative early breast cancer
Caroline Lohrisch · BC Cancer Agency
2017–2020 · research · Breast Cancer Research Grants Program
Control of breast cancer by cooperation between the PI4KIIIB lipid kinase and the Rab11a GTPase
Jonathan Lee · University of Ottawa
2017–2020 · research · Breast Cancer Research Grants Program
Prospective cohort study evaluating risk of local recurrence following breast conserving surgery alone in low risk luminal A breast cancer
Timothy Whelan · McMaster University
2017–2019 · research · Prevention Innovation Grants
Metabolomics as a new strategy to understand modifiable factors for cancer prevention
Rachel Murphy · University of British Columbia
